WAM
RCKTW icon

Wolverine Asset Management’s Rocket Pharmaceuticals Warrant RCKTW Stock Holding History

Wolverine Asset Management’s Portfolio RCKTW Stock Details RCKTW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-4,615
Closed -$754 – 1914
2023
Q1 		$754 Buy
+4,615
New +$890 ﹤0.01% 1732

Other funds holding RCKTW

BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
FBCM
Fort Baker Capital Management Larkspur, California $1.37B AUM 26.91% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return

Wolverine Asset Management's RCKTW Position: Q2 2023 in Review

Wolverine Asset Management sold out of Rocket Pharmaceuticals Warrant (RCKTW) in Q2 2023, closing a stake of 4,615 shares — an estimated $754 sold.

Wolverine Asset Management first reported a position in RCKTW in Q1 2023 and held it in 1 quarter. The position peaked at $754 in Q1 2023. 16 funds tracked by Wall St. Rank hold RCKTW as of Q2 2023.

  • Wolverine Asset Management reported no remaining Rocket Pharmaceuticals Warrant position as of Q2 2023 after selling out during the quarter.
  • Wolverine Asset Management sold 4,615 Rocket Pharmaceuticals Warrant shares in Q2 2023, an estimated $754.
  • Wolverine Asset Management first reported a position in Rocket Pharmaceuticals Warrant in Q1 2023 and held it in 1 quarter.
  • Wolverine Asset Management's Rocket Pharmaceuticals Warrant position peaked at $754 in Q1 2023.
  • 16 funds tracked by Wall St. Rank held Rocket Pharmaceuticals Warrant as of Q2 2023.

Based on Wolverine Asset Management's 13F filing for Q2 2023, filed 7 Aug 2023.